Articles

Podcasts

Videos

An overview of new gene therapy options for wet AMD that are currently being explored in clinical trials.  

Intravitreal Gene Therapy for Wet AMD 

Results of recent phase III clinical trials with respect to efficacy and safety of faricimab, an investigational bispecific antibody which inhibits both VEGF-A and angiopoietin-2.   

Faricimab: A New Bispecific Antibody with Promising Durability in AMD 

A panel of retinal experts developed definitions for and classified the reasons behind patient nonadherence and nonpersistence. 


Experts Define Nonadherence, Nonpersistence to Anti-VEGF Therapy for nAMD

Retina specialists provide insight into the patient selection and safety concerns with the innovative Port Delivery System (PDS) that offers a new means of sustained anti-VEGF therapy.

Port Delivery System for AMD: Patient Selection and Safety Insights 

Carl Regillo, MD highlights the Port Delivery System (PDS), a new surgical implant with sustained release of anti-VEGF therapy that recently completed phase III clinical trials.  

The Port Delivery System: A Novel Sustained Release Treatment Option in AMD 

The ortho-k lenses are fitted to a patient's eye using a corneal shape to temporarily reshape the cornea. 

FDA Approves Orthokeratology Contact Lenses For Myopia Management

Dr Arshad Khanani highlights various strategies currently under investigation for the treatment of age-related macular degeneration and explains the impact long-term data and real-world evidence has on his treatment decisions. 

Newer Therapies for AMD and Supporting Data 

Considerations for treating patients with diabetes who have wet age-related macular degeneration with faricimab to reduce treatment burden based on results of recent clinical trials. 

Faricimab Data for Diabetic Patients With AMD 

Research at ARVO 2021 highlighted a gamut of interplaying diabetes and vision loss risk factors, and even treatments for both. But experts depict a referral and care process that lacks whole diabetes care.

Diabetic Vision Loss Care Lacks Specialty Collaborations

A podcast interview with study author Paul Yang, MD, PhD, on the current research and future implementation of the agent.

Gene Therapy AGTC-501 Hits Phase 1/2 Marks for Rare Pediatric Blindness

Diabetic Macular Edema

The HCPLive diabetic macular edema page is a comprehensive resource for clinical news and insights on DME. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for the leading cause of blindness, and more.

Uveitis

The HCPLive uveitis page is a comprehensive resource for clinical news and insights on chorioretinitis. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for eye inflammation, and more.

Ophthalmology page, resources on the topics of medical news and expert insight into ophthalmic disease can be found. Content includes articles, interviews, videos, podcasts, and breaking news on eye disease research, treatment, and drug development.